Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CROX - US2270461096 - Common Stock

86.57 USD
+1.07 (+1.25%)
Last: 1/8/2026, 8:00:01 PM
86.75 USD
+0.18 (+0.21%)
After Hours: 1/8/2026, 8:00:01 PM
Fundamental Rating

7

CROX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. CROX may be a bit undervalued, certainly considering the very reasonable score on growth This makes CROX very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
CROX had a positive operating cash flow in the past year.
In the past 5 years CROX has always been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.25%, CROX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of 13.39%, CROX is doing good in the industry, outperforming 73.33% of the companies in the same industry.
CROX has a Return On Invested Capital of 23.59%. This is amongst the best in the industry. CROX outperforms 91.11% of its industry peers.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.62%.
The 3 year average ROIC (22.59%) for CROX is below the current ROIC(23.59%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROIC 23.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

Looking at the Profit Margin, with a value of 4.48%, CROX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX has a Operating Margin of 23.11%. This is amongst the best in the industry. CROX outperforms 95.56% of its industry peers.
CROX's Operating Margin has improved in the last couple of years.
The Gross Margin of CROX (59.08%) is better than 75.56% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CROX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CROX has been reduced compared to 5 years ago.
CROX has a better debt/assets ratio than last year.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.76. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.76, CROX is doing good in the industry, outperforming 71.11% of the companies in the same industry.
CROX has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.84, CROX belongs to the top of the industry, outperforming 84.44% of the companies in the same industry.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.97, CROX is not doing good in the industry: 75.56% of the companies in the same industry are doing better.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Altman-Z 3.76
ROIC/WACC2.03
WACC11.63%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.40 indicates that CROX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, CROX is doing worse than 80.00% of the companies in the same industry.
CROX has a Quick Ratio of 1.40. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.83, CROX is doing worse than 66.67% of the companies in the same industry.
CROX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.83
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for CROX have decreased by -4.09% in the last year.
Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 51.64% on average per year.
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.01%.
Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 27.23% on average per year.
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%

3.2 Future

CROX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.84% yearly.
The Revenue is expected to grow by 2.29% on average over the next years.
EPS Next Y-6.35%
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%
EPS Next 5Y2.84%
Revenue Next Year-1.85%
Revenue Next 2Y-1.15%
Revenue Next 3Y-0.38%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.83, the valuation of CROX can be described as very cheap.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 93.33% of the companies are valued more expensively.
CROX is valuated cheaply when we compare the Price/Earnings ratio to 27.00, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.10, the valuation of CROX can be described as very cheap.
Based on the Price/Forward Earnings ratio, CROX is valued cheaper than 95.56% of the companies in the same industry.
CROX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.70.
Industry RankSector Rank
PE 6.83
Fwd PE 7.1
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued cheaply inside the industry as 91.11% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CROX is valued cheaply inside the industry as 91.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.28
EV/EBITDA 5.56
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CROX has an outstanding profitability rating, which may justify a higher PE ratio.
CROX's earnings are expected to decrease with -2.20% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CROCS INC

NASDAQ:CROX (1/8/2026, 8:00:01 PM)

After market: 86.75 +0.18 (+0.21%)

86.57

+1.07 (+1.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners99.37%
Inst Owner Change0%
Ins Owners2.89%
Ins Owner Change1.91%
Market Cap4.49B
Revenue(TTM)4.07B
Net Income(TTM)182.55M
Analysts74.55
Price Target92.99 (7.42%)
Short Float %13.32%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.3%
Min EPS beat(2)3.5%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)13.09%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.48%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.48%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)-0.42%
PT rev (3m)-0.12%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)6.9%
EPS NY rev (1m)0.05%
EPS NY rev (3m)5.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.57%
Valuation
Industry RankSector Rank
PE 6.83
Fwd PE 7.1
P/S 1.1
P/FCF 6.28
P/OCF 5.76
P/B 3.3
P/tB N/A
EV/EBITDA 5.56
EPS(TTM)12.67
EY14.64%
EPS(NY)12.19
Fwd EY14.09%
FCF(TTM)13.79
FCFY15.93%
OCF(TTM)15.02
OCFY17.35%
SpS78.44
BVpS26.25
TBVpS-7.17
PEG (NY)N/A
PEG (5Y)0.13
Graham Number86.51
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROCE 26.08%
ROIC 23.59%
ROICexc 24.64%
ROICexgc 49.52%
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
FCFM 17.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Debt/EBITDA 1.3
Cap/Depr 83.38%
Cap/Sales 1.56%
Interest Coverage 11.87
Cash Conversion 76.65%
Profit Quality 392.36%
Current Ratio 1.4
Quick Ratio 0.83
Altman-Z 3.76
F-Score6
WACC11.63%
ROIC/WACC2.03
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
EPS Next Y-6.35%
EPS Next 2Y-3.7%
EPS Next 3Y-2.2%
EPS Next 5Y2.84%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%
Revenue Next Year-1.85%
Revenue Next 2Y-1.15%
Revenue Next 3Y-0.38%
Revenue Next 5Y2.29%
EBIT growth 1Y-11.62%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-7.67%
EBIT Next 3Y-5.26%
EBIT Next 5Y3.43%
FCF growth 1Y-14.34%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-16.78%
OCF growth 3Y20.5%
OCF growth 5Y61.62%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CROX.


Can you provide the valuation status for CROCS INC?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 9 / 10.


What is the earnings growth outlook for CROCS INC?

The Earnings per Share (EPS) of CROCS INC (CROX) is expected to decline by -6.35% in the next year.


Is the dividend of CROCS INC sustainable?

The dividend rating of CROCS INC (CROX) is 0 / 10 and the dividend payout ratio is 0%.